Abstract:Li-Hua Deng, 1, 2 Hai Jiang, 1 Fu-Lin Lu, 1 Han-Wei Wang, 1 Yu Pu, 1 Chang-Qiang Wu, 1 Hong-Jie Tang, 3 Ye Xu, 4 Tian-Wu Chen, 1 Jiang Zhu, 1 Cheng-Yi Shen, 1 Xiao-Ming Zhang 1 1 Medical Imaging Key Laboratory of Sichuan Province and School of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China; 2 Department of Radiology, First People's Hospital of Neijiang, Neijiang 641000, People's Republic of China; 3 Department of Radiology, Nanchong Hospital of Traditional Chinese Medicine, Nanchong 637000, People's Republic of China; 4 Department of Radiology, Children's Hospital of Chongqing Medical University, Chongqing 401122, People's Republic of China Correspondence: Chang-Qiang Wu; Xiaoming Zhang Sichuan Key Laboratory of Medical Imaging and School of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, 234th Fujiang Road, Nanchong 637000, People's Republic of China Tel +86-13990723836 Email wucq1984@163.com; zhangxm@nsmc.edu.cn Objective: PEGylated superparamagnetic iron oxide (SPIO) is the most promising alternatives to gadolinium-based contrast agents (GBCAs) in MRI. This paper is to explore the imaging effects of PEGylated SPIO, which is influenced by particle sizes and surface polyethylene glycol (PEG) coating, using as MRI contrast agents at different magnetic field intensities. Methods: Firstly, nine PEGylated monocrystalline SPIO nanoparticles with different nanocrystal sizes and different molecular weights PEG coating were prepared, and then physical and biological properties were analyzed. Finally, MRI imaging in vivo was performed to observe the imaging performance. Results: Nine PEGylated monocrystalline SPIO nanoparticles have good relaxivities, serum stability, and biosecurity. At the same time, they show different imaging characteristics at different magnetic field intensities. Eight-nanometer SPIO@PEG5k is an effective T 2 contrast agent at 3.0 T ( r 2 / r 1 = 14.0), is an ideal T 1 - T 2 dual-mode contrast agent at 1.5 T ( r 2 / r 1 = 6.52), and is also an effective T 1 contrast agent at 0.5 T ( r 2 / r 1 = 2.49), while 4-nm SPIO@PEG5k is a T 1 - T 2 dual-mode contrast agent at 3.0 T ( r 2 / r 1 = 5.24), and is a useful T 1 contrast agent at 0.5 T ( r 2 / r 1 = 1.74) and 1.5 T ( r 2 / r 1 = 2.85). MRI studies in vivo at 3.0 T further confirm that 4-nm SPIO@PEG5k displays excellent T 1 - T 2 dual-mode contrast enhancement, whereas 8-nm SPIO@PEG5k only displays T 2 contrast enhancement. Conclusion: PEGylated SPIOs with different nanocrystal sizes and PEG coating can be used as T 1 , T 2 , or T 1 - T 2 dual-mode contrast agents to meet the clinical demands of MRI at specific magnetic fields. Keywords: magnetic resonance imaging, contrast agents, superparamagnetic iron oxide, polyethylene glycol

Characterization and in Vitro Cellular Uptake of PEG Coated Iron Oxide Nanoparticles As MRI Contrast Agent.

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Effects of iron oxide nanoparticle labeling on human endothelial cells.

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent

Investigation of magnetic resonance contrast properties of PEG-Coated gadolinium oxide nanoparticles in various biological environments

Effects of PEG Chain Length on Relaxometric Properties of Iron Oxide Nanoparticles-Based MRI Contrast Agent

Magnetic resonance signal detection of superparamagnetic iron oxide nanoparticles and its biological effects on endothelial cells]

Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia.

Precise Study on Size-Dependent Properties of Magnetic Iron Oxide Nanoparticles for in Vivo Magnetic Resonance Imaging

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

PEG- b -AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Synthesis and Characterization of PVP-coated Large Core Iron Oxide Nanoparticles As an MRI Contrast Agent.

Effective PEGylation of Fe<SUB>3</SUB>O<SUB>4</SUB> Nanomicelles for <i>in Vivo</I> MR Imaging

Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide Nanoparticles

Delayed hepatic uptake of multi-phosphonic acid poly(ethylene glycol) coated iron oxide measured by real-time Magnetic Resonance Imaging

PEGylation of iron doped hydroxyapatite nanoparticles for increased applicability as MRI contrast agents and as drug vehicles: A study on thrombogenicity, cytocompatibility and drug loading

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

Effective Pegylation of Iron Oxide Nanoparticles for High Performance in Vivo Cancer Imaging